ERLINA 10/5MG TAB

ERLINA 10/5MG is a combination tablet containing Empagliflozin and Linagliptin, designed to help manage type 2 diabetes. Empagliflozin works by helping your kidneys remove excess glucose through urine, while Linagliptin enhances insulin secretion when blood sugar levels are elevated. This dual-action formula helps improve blood sugar control and may support better glycemic management. Take as directed by your healthcare provider. Suitable for adults with type 2 diabetes who require combination therapy.